ArticleMDM policy & practice

Patients' Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer.

Brian De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.